China's Refining Industry Faces Major Shakeup Amid Challenges 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
South Korea to End Short-Selling Ban as Financial Market Uncertainty Persists 
Ferrari Group to Launch IPO in Amsterdam, Targets Over $1 Billion Valuation 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors 
Why your retirement fund might soon include cryptocurrency 
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth 
Why the Middle East is being left behind by global climate finance plans 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
